FDA clears TopiVert's IND for phase I/IIa study of TOP-1630 in dry eye syndrome Nov. 28, 2016 No Comments
Ocular Therapeutix reports positive results for phase III trial of Dextenza Nov. 15, 2016 No Comments
Aganirsen given FDA orphan designation for preventing corneal graft rejection Nov. 10, 2016 No Comments
Applied Genetic Technologies files IND for second achromatopsia therapeutic candidate Oct. 20, 2016 No Comments
RSS